Cancer drug approvals and setbacks in 2023doi:10.1038/s43018-023-00683-zElie DolginNature Cancer
Nature Cancer volume 4, pages 1612–1614 (2023)Cite this article 3062 Accesses 5 Altmetric Metrics details Bispecific T cell engagers and antibody–drug conjugates took center stage in a year that also brought several new kinds of small-molecule therapies. This is a preview of subscription ...
Chemotherapy is drug therapy for cancer. It works by killing the cancer cells, stopping them from spreading, or slowing their growth. However, it can also harm healthy cells, which causes side effects. Cancer can be treated by surgery, chemotherapy, radiation therapy, hormonal therapy, targeted ...
The drug received EU approval at the end of July 2024 and the UK go-ahead in October. Kexing said it has already completed preparations for shipping to several European countries. Global sales of Albumin-bound Paclitaxel drugs stood at about USD2.597 billion in 2023...
Clinical Benefit of Drug-Indication Pairs Granted Accelerated Approval Between 2013 and 2017 That Have Been Converted to Regular Approval eTable 2. Examples of Indication Changes Between Accelerated and Regular Approval eTable 3. Indications of Oncology Drugs Receiving Accelerated After January 2013 and ...
癌痛是癌症相关疼痛的简称,疼痛往往是因肿瘤直接造成,或是癌症相关的治疗带来的疼痛。癌痛会影响病人睡眠、饮食,严重者造成抑郁状态。合理正确的使用镇痛药物可以有效缓解疼痛,降低镇痛药带来的副作用。那么,癌痛病人应当如何正确服用镇痛药物呢?以下小知识是您需要了解的!
Personalized cancer treatments using combinations of drugs with a synergistic effect is attractive but proves to be highly challenging. Here we present an approach to uncover the efficacy of drug combinations based on the analysis of mono-drug effects. F
Brana I, Siu LL. Locally advanced head and neck squamous cell cancer: treatment choice based on risk factors and optimizing drug prescription. Ann Oncol. 2012;23(Suppl 10):x178–85. Article Oliver RJ, Clarkson JE, Conway DI, Glenny A, Macluskey M, Pavitt S, et al. Interventions for th...
[1]研究结果显示,在既往辅助/新辅助治疗期间接受曲妥珠单抗的HER2乳腺癌吡咯替尼紫杉醇(ORR)为92.6%,疾病控制率(DCR)为100%,中位无进展生存期(mPFS)尚未成熟,且TLR3和RET可能作为患者无进展生存的潜在预测蛋白。 该研究在2022年GBCC(全球乳腺癌学术大会)、2023年SABCS(圣安东尼奥乳腺癌研讨会)相继亮相后再传捷报...
or enter the cancer cells. Additionally, the bacteria that coat cancer cells release DNA and various proteins that prevent the tumor from spreading [294,295]. To create naturally occurring nanowires that may be used as drug carriers for cancer treatment, Kumeria and colleagues [296] synthesized ...